Home News Covid-19: Novavax vaccine reveals 89% efficacy in UK trials

Covid-19: Novavax vaccine reveals 89% efficacy in UK trials

52
0
Covid-19: Novavax vaccine reveals 89% efficacy in UK trials

The Novavax jab is the primary to indicate in trials that it’s efficient towards the UK variant of the virus.